updated 11/8/2010 6:46:12 AM ET 2010-11-08T11:46:12

SAN DIEGO, Nov. 5, 2010 (GLOBE NEWSWIRE) -- The MyGlucoHealth diabetes management system recently received regulatory approval in India. The MyGlucoHealth system includes the MyGlucoHealth Wireless glucometer, test strips, mobile phone application and online portals. Regulatory approval from Central Drugs Standard Control Organisation, (Food and Drug Administration Bhavan, New Delhi) ensures that MyGlucoHealth strips meets Indian standards of quality, safety, and efficacy. The MyGlucoHealth license number is NCD 145/10.

"India is often referred to as the 'diabetes capital of the world,' with the highest number of diabetic patients of any country," said Richard Strobridge, CEO of Entra Health Systems, maker of MyGlucoHealth. "MyGlucoHealth offers a comprehensive solution to help over 40 million diabetics in India better manage their condition using a mobile phone and online services. Since most Indians have mobile phones, but few have computers, we have developed a unique solution, in conjunction with major clinical care groups in India, to enable patients to upload test results to the MyGlucoHealth online portal using SMS messaging technology. This gives users access to the alerts and messaging features of MyGlucoHealth without the need for costly data plans."

MyGlucoHealth provides a quick and convenient way for persons with diabetes to measure and self-manage blood glucose levels. Using automated tools, MyGlucoHealth sends reminders to encourage patients to test more frequently, as well as to notify family, caregivers and clinicians when testing results reach critical levels. MyGlucoHealth gives patients more direct control over their care and provides clear lines of communication with clinicians and caregivers.

The MyGlucoHealth Wireless blood glucose meter and other consumables will be available throughout India in the coming months. For information on product availability or distribution opportunities within India, contact Shailesh Gadre, director of GCV Life Pvt. Ltd. in Mumbai, info@gcvlife.in

About MyGlucoHealth®

MyGlucoHealth Wireless from Entra Health Systems is the first and only FDA cleared and CE certified Bluetooth®-enabled glucometer of its kind in the world. MyGlucoHealth works in combination with a real-time online data collection network to securely upload and manage blood glucose readings using a mobile phone or PC eliminating the need to maintain personal logbooks.

The meter, along with the MyGlucoHealth Network, form an integrated telehealth platform supporting patients and healthcare professionals in the control and treatment of diabetes. For more information visit: www.myglucohealth.net

The MyGlucoHealth Wireless logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6117

About GCV Life

Emerging markets undoubtedly represent an attractive opportunity for many a healthcare companies owing to their vast untapped potential; however, the clinical needs in these markets and the business models needed to address them may be substantially different from those in vogue in the developed markets. GCV Life is an investment banking firm focused on bringing about 'healthcare commercialization' in emerging markets. GCV Life picks-up new areas of disease management / technological innovations and facilitate access to innovators into emerging markets. 

GCV Life's mission is to provide knowledge-driven access to business synergies. www.gcvlife.in

© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved


Discussion comments


Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 3.79%
$30K home equity loan FICO 4.99%
$75K home equity loan FICO 4.69%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.83%
Cash Back Cards 17.80%
Rewards Cards 17.18%
Source: Bankrate.com